Guardian Pharmacy Services (GRDN) executive compensation, 2026 proxy

Fred Burke, President and Chief Executive Officer, was paid $845,842 in 2025, up 10% from $766,103 the year before.

Filed
March 26, 2026
Annual meeting
May 5, 2026
Pay year
2025
Named executives
3
CEO total pay
$845,842+10% vs prior year
CEO Target Bonus Percentage
60%Expressed as percentage of base salary.
Maximum Incentive Payout
125%Paid out at maximum level for 2025.
Adjusted EBITDA
$115.1MPerformance metric achieved for 2025.
Company Revenue
$1.45BPerformance metric achieved for 2025.
Pharmacy Locations Added
5Achieved maximum target.

How Burke was paid

$845,842 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary55%Non-equity incentive41%All other compensation4%

Named executive officers

ExecutiveTotal
Fred BurkePresident and Chief Executive Officer$845,842
David MorrisExecutive Vice President and Chief Financial Officer$996,704
Kendall ForbesExecutive Vice President, Sales & Operations$994,734

What changed and why

  • $846KCEO total compensation increased to $845,842 in 2025 from $766,103 in 2024.
  • 125%Annual cash incentive payouts were achieved at the maximum level of 125% of target.
  • $1.45BCompany revenue reached $1.45 billion and Adjusted EBITDA reached $115.1 million in 2025.
  • Mr. Burke did not receive any equity awards in 2025 at his request.
  • $240KMr. Morris and Mr. Forbes each received $239,997 in restricted stock units under the 2025 LTIP.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.